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A B S T R A C T
Tetanus vaccination is part of the Norwegian childhood vaccination program. An elderly woman injured
her arm and leg after a minor fall on her outdoor stairs. Two weeks later she presented with trismus. This
developed into tetanic spasms, obstructed airways and the need for a tracheostomy. She died 14 days
later due to pneumonia and multi-organ failure. ELISA for tetanus toxoid IgG was negative, probably
because the patient was born before the introduction of tetanus vaccination in the Norwegian childhood
vaccination program. Lack of adherence to the vaccination programs should be considered in patients
presenting with symptoms resembling diseases they normally would be protected from. Although the
patient presented with typical symptoms the diagnosis was not suspected initially, probably due to the
rareness of this disease in Norway.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The tetanus vaccine has been available in Norway since 1945
but has only been a part of The Norwegian Childhood Immuniza-
tion Program since 1952. All children residing in Norway are
offered participation in this program, which includes immuniza-
tion against tetanus starting at the age of 3 months and ﬁnishing at
the age of 16 years. Vaccination is not compulsory. The vaccination
coverage is 91–95% [1].
Case report
The patient was a 94-year old woman with macular degenera-
tion, hypertension and depression. She used hydrochlorothiazide–
amilorid and escitalopram and received monthly intraocular
injections of bevacizumab. The patient lived at home and cared
for herself but had home based nursing help once a week.
She ﬁrst contacted her dentist 1 week prior to admission to
hospital due to trismus and suspicion of a dental infection. No
dental infection was found and no further dental care was given.* Corresponding author at: Lovisenberg Diaconal Hospital, Oslo, Norway.
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4.0/).The patient then developed difﬁculties speaking and a left sided
spasticity. She was admitted to her local hospital with a suspicion
of a cerebrovascular event.
At her local hospital a computer tomography scan of the brain
and facial skeleton was performed but no intracerebral bleeding or
infarction was found and no abnormalities of the facial bone
structure was seen. CT revealed chronic dental infection of the
teeth 14, 26 and 45.
Under the suspicion of a neurological disease due to trismus
and spasticity in her facial muscles, the patient was transferred to
the Neurological Department at the Oslo University Hospital. At
the University Hospital the patient was seen by an oral surgeon but
he was not able to open the patient’s mouth for further
examination. Diazepam did not relax the patient’s facial muscles
and evaluation was done by exterior observation, evaluation of the
CT-scans and palpation of the face and jaw.
A neurologist was also not able to open the patient’s mouth but
had the impression the patient was awake, alert and oriented for
time and space. During the examinations the patient suffered
seizures with neck and facial cramps, and experienced difﬁculties
swallowing and breathing. Tetanus was suspected and the patient
was moved to the Intensive Care Unit (ICU).
In the ICU, the patient communicated by nodding and shaking
her head and her responses were appropriate. Laryngeal spasms
and airway compromise intervened and a tracheostomy wase under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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enced a spastic seizure (opisthotonus) involving the whole upper
part of her body.
After the tracheostomy, the patient was easier to ventilate and
monitor so her previous history could be assessed more
thoroughly. It appeared that 1–2 weeks prior to the start of her
symptoms she had fallen on her outdoor stone steps and hurt/
grazed her left arm and right leg. The wounds were quite
superﬁcial and she had not sought medical attention for this.
We therefore contacted the plastic surgeon who performed wound
excision. Samples of the excised skin were sent for culturing.
Benzylpenicillin was started and tetanus immune globulin
(3000 IU) was administered. The patient was sedated and kept
on a ventilator. She was kept in a dark room with as few stimuli as
possible.
The next day the patient had another seizure with extension of
the neck, trismus and spasticity in all extremities after minor
stimulation. A chest X-ray showed possible inﬁltration in her right
lung and C-reactive protein (CRP) increased from 7 to 16 mg/L.
Pneumonia possibly caused by aspiration was suspected and
metronidazole was added to penicillin. EEG did not show any
epileptic activity.
During the next 2 days her CRP increased to 80 mg/L and she
became febrile. Lung physiotherapy was not possible due to
increased spasms during all manipulation of the patient. Sedation
was increased. Culturing of samples from her wounds on her
extremities showed Staphylococcus aureus and clindamycin was
added to the antimicrobial regimen.
Upon admission to the ICU when tetanus was suspected,
serological testing was performed. Speciﬁc IgG antibodies to
tetanus toxoid were measured by an ELISA technique [2]. The
result of the analysis showed that the tetanus toxoid IgG antibody
level was <0.1 IU/ml – i.e. the patient had no immunity to tetanus.
Eight days after admission, the CRP values increased to 274 mg/
L and the frequency of the spasms increased. The antibiotic
regimen was changed to piperacillin–tazobactam and the patient
was given more sedation. Pneumonia was still suspected as the
main complicating infection. After this the situation rapidly
deteriorated and she died 12 days after admission from multiple
organ failure.
Discussion
Tetanus is a rare disease in Norway. From registration started in
1977 to the current case in 2012 only 49 cases had been reported to
the Norwegian Surveillance System for Communicable Diseases
(MSIS) at the Norwegian Institute of Public Health (FHI), of which
three cases were fatal (this case included). A major contributor to
this low number is probably the immunization program, which
was introduced in Norway in 1952. The incidence of tetanus has
dropped dramatically after the introduction of the tetanus toxoid
vaccine. The US Centers for Disease Control and Prevention (CDC)
reported for the period 2001–2007 an overall annual incidence of
0.10 and 0.23 cases/million among individuals >65 years of age [3].
The incidence of tetanus in European countries is also low and has
declined due to vaccination programs [4,5]. Until the 1950s 10–15
Norwegians died annually from tetanus [1]. Today the disease is
most common among older people with penetrating skin injuries
and where the wound surface has come in contact with infected
soil. Most patients born before 1950 have not been primary
vaccinated against tetanus. A recent published article from the
United Kingdom highlights the importance of tetanus risk
management during wound management [6].
The diagnosis of tetanus is mainly based on clinical criteria. A
serum IgG antibody level to tetanus toxoid of more than 0.1 IU/ml
measured with ELISA technique is considered protective. However,tetanus disease has occurred in individuals with antibody levels of
0.15 IU/ml measured with ELISA [7]. There is no speciﬁc test to
diagnose tetanus and the organism is most often not recovered
from the site of infection. Our diagnosis of tetanus seems
convincing, with the absence of antitoxin antibodies and a typical
history and symptoms.
Although the diagnosis of tetanus is usually obvious there are
several differential diagnoses:
1. From an epidemiological point of view a cerebrovascular event
would be much more likely and it would be natural to look for
cerebral infarcts or bleeding in a patient with hypertension
presenting with (what was considered to be) aphasia and
spasticity of one part of the body. Although a CT-scan of the head
was performed a recent cerebral infarction is often not visible
the ﬁrst days after the event. In this case the patient contacted
the hospital more than 1 week after the presentation of
symptoms and signs of infarction (and bleeding) would
probably have been visible on CT-imaging. Cerebral infarcts/
bleeding are common diagnoses in the elderly patient with
hypertension and recent development of neurological symp-
toms. And the suspicion of this should probably be one of the
ﬁrst diagnoses to be evaluated.
2. Trismus due to dental infection was the original diagnosis and
may be confused with (cephalic) tetanus. Muscle spasms would
normally not progress in a patient with dental infection.
3. Malignant neuroleptic syndrome can present with muscular
rigidity. Patients with this condition will normally have a history
of recent intake of a neuroleptic drug, many will have a fever and
an altered mental status.
Our patient’s symptoms were bilateral with a typical facial
expression, trimus and spastic seizures. The diagnosis of tetanus was
still not obvious probably due to the low prevalence of this condition
in Norway. The recent history of trauma was also delayed since the
injuries were small and relatively innocent. Interestingly the
primary site of entry of the infection, as in this case, might be quite
superﬁcial and the wound might have healed at the time of tetanus
development. The incubation period is between 1 day and several
months with most cases occurring within 8 days [8–12] depending
on the amount of the inoculum and the distance from the
introduction of spores through the skin and the central nervous
system. Our patient had wounds on her arm and leg which were
consistent with an incubation period of 1–2 weeks prior to symptom
development. Her skin injuries were superﬁcial but they did
penetrate the skin and left the tissue beneath open for microbial
invasion. Clostridium tetani will not grow in healthy tissue and
penetrating injuries or devitalized tissue is necessary for tetanus
toxin to be released in the human body. It is not the clostridial
bacterium but the released toxin (tetanospasmin) that causes the
symptoms. In many cases the wound has healed at the time of
presentation of the muscular symptoms.
The wound debridement was probably done too late since the
wounds had more or less healed at the time of presentation of the
symptoms. The role of antibiotics is also probably small in the
management of tetanus but in the absence of better alternatives
most patients receive penicillin and/or metronidazole.
One of the major pharmacies in Oslo has at all times an
emergency supply of human tetanus immune globulin (HTIG). This
was administered within 2 h of the clinical diagnosis of tetanus
being made. HTIG binds to unbound tetanus toxin and neutralizes
this. The already bound fraction of toxin is irreversibly bound and
is not available for neutralization [8,13].
One of the major problems in the treatment of our and many
other tetanus patients is the obstruction of the airways, and
airways management should always be a top priority. In our case
B. Brandsæter et al. / IDCases 2 (2015) 53–55 55the patient needed tracheostomy to secure the airways. Normal
intubation was not possible and not feasible due to her trismus.
In developed countries most patients survive if intensive care
facilities and modern supportive treatment is available [14]. In
developing countries the fatality rate is 8–50% for non-neonatal
tetanus [15]. The challenge is to keep the patient stable and free of
complications during the recovery phase which requires growth of
new axonal nerve terminals.
Conclusion
Tetanus can still occur among non-immunized patients in
countries where immunization is available. Patients without a
history of receiving a full series of tetanus vaccination, and who
experience a skin penetrating injury with potential introduction of
C. tetani spores are at risk and should be considered for vaccination
and treatment. A typical clinical picture of tetanus could be
tetanus, even in Norway.
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